These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1534823)

  • 21. Defective clonal deletion and anergy induction in TCR transgenic lpr/lpr mice.
    Mountz JD; Bluethmann H; Zhou T; Wu J
    Semin Immunol; 1994 Feb; 6(1):27-37. PubMed ID: 8167304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal deletion of immature CD4+8+ thymocytes in suspension culture by extrathymic antigen-presenting cells.
    Swat W; Ignatowicz L; von Boehmer H; Kisielow P
    Nature; 1991 May; 351(6322):150-3. PubMed ID: 1903182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The balance between deletion and activation of CD4+8+ thymocytes is controlled by T cell receptor-antigen interactions and is affected by cyclosporin A.
    Curnow SJ; Schmitt-Verhulst AM
    Eur J Immunol; 1994 Oct; 24(10):2401-9. PubMed ID: 7925567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structurally distinct T cell receptor complexes on developmentally distinct T cell populations in severe combined immunodeficiency mice expressing a TCR beta transgene.
    Shores EW; Nakayama T; Wiest DL; Takahama Y; Sharrow S; Singer A
    J Immunol; 1993 Feb; 150(4):1263-75. PubMed ID: 8094405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and function of mouse Fas antigen on immature and mature T cells.
    Nishimura Y; Ishii A; Kobayashi Y; Yamasaki Y; Yonehara S
    J Immunol; 1995 May; 154(9):4395-403. PubMed ID: 7536770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model for the origin of TCR-alphabeta+ CD4-CD8- B220+ cells based on high affinity TCR signals.
    Mixter PF; Russell JQ; Morrissette GJ; Charland C; Aleman-Hoey D; Budd RC
    J Immunol; 1999 May; 162(10):5747-56. PubMed ID: 10229807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T cell tolerance.
    Walunas TL; Sperling AI; Khattri R; Thompson CB; Bluestone JA
    J Immunol; 1996 Feb; 156(3):1006-13. PubMed ID: 8557973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic differences between alpha beta versus beta T-cell receptor transgenic mice undergoing negative selection.
    Berg LJ; Fazekas de St Groth B; Pullen AM; Davis MM
    Nature; 1989 Aug; 340(6234):559-62. PubMed ID: 2528070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin A inhibits positive selection and delays negative selection in alpha beta TCR transgenic mice.
    Urdahl KB; Pardoll DM; Jenkins MK
    J Immunol; 1994 Mar; 152(6):2853-9. PubMed ID: 8144886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central T cell tolerance in lupus-prone mice: influence of autoimmune background and the lpr mutation.
    Fatenejad S; Peng SL; Disorbo O; Craft J
    J Immunol; 1998 Dec; 161(11):6427-32. PubMed ID: 9834135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells.
    Zelenika D; Adams E; Mellor A; Simpson E; Chandler P; Stockinger B; Waldmann H; Cobbold SP
    J Immunol; 1998 Aug; 161(4):1868-74. PubMed ID: 9712055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses.
    Fujihashi K; Yamamoto M; McGhee JR; Kiyono H
    J Immunol; 1993 Dec; 151(12):6681-91. PubMed ID: 7903096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice.
    Lieberman SA; Spain LM; Wang L; Berg LJ
    Cell Immunol; 1995 Apr; 162(1):56-67. PubMed ID: 7704911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opposite CD4/CD8 lineage decisions of CD4+8+ mouse and rat thymocytes to equivalent triggering signals: correlation with thymic expression of a truncated CD8 alpha chain in mice but not rats.
    Mitnacht R; Bischof A; Torres-Nagel N; Hünig T
    J Immunol; 1998 Jan; 160(2):700-7. PubMed ID: 9551905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell expansion and growth arrest phases during the transition from precursor (CD4-8-) to immature (CD4+8+) thymocytes in normal and genetically modified mice.
    Pénit C; Lucas B; Vasseur F
    J Immunol; 1995 May; 154(10):5103-13. PubMed ID: 7730616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct stage-specific cis-active transcriptional mechanisms control expression of T cell coreceptor CD8 alpha at double- and single-positive stages of thymic development.
    Zhang XL; Seong R; Piracha R; Larijani M; Heeney M; Parnes JR; Chamberlain JW
    J Immunol; 1998 Sep; 161(5):2254-66. PubMed ID: 9725219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerance induction by clonal deletion of CD4+8+ thymocytes in vitro does not require dedicated antigen-presenting cells.
    Pircher H; Brduscha K; Steinhoff U; Kasai M; Mizuochi T; Zinkernagel RM; Hengartner H; Kyewski B; Müller KP
    Eur J Immunol; 1993 Mar; 23(3):669-74. PubMed ID: 8095457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance induction as a multi-step process.
    Schönrich G; Alferink J; Klevenz A; Küblbeck G; Auphan N; Schmitt-Verhulst AM; Hämmerling GJ; Arnold B
    Eur J Immunol; 1994 Feb; 24(2):285-93. PubMed ID: 8299678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.